Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MDGL Madrigal Pharmaceuticals, Inc.

休市中 08-23 16:00:00 EDT

252.74

+4.06

+1.63%

盘后252.74

+0.000.00%

19:18 EDT

最高254.00	最低247.38	成交量16.02万
今开247.50	昨收248.68	日振幅2.66%
总市值54.88亿	流通市值26.85亿	总股本2,171万
成交额4,037万	换手率1.51%	流通股本1,062万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MDGL","market":"US","secType":"STK","nameCN":"Madrigal Pharmaceuticals, Inc.","latestPrice":252.74,"timestamp":1724443200000,"preClose":248.68,"halted":0,"volume":160168,"hourTrading":{"tag":"盘后","latestPrice":252.74,"preClose":252.74,"latestTime":"19:18 EDT","volume":6343,"amount":1603067.84,"timestamp":1724455131863},"delay":0,"floatShares":10624162,"shares":21712677,"eps":-25.63264,"marketStatus":"休市中","marketStatusCode":7,"change":4.06,"latestTime":"08-23 16:00:00 EDT","open":247.5,"high":254,"low":247.38,"amount":40374423.87896,"amplitude":0.026621,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-25.63264,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":248.68,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":252.74,"preClose":252.74,"latestTime":"19:18 EDT","volume":6343,"amount":1603067.84,"timestamp":1724455131863},"volumeRatio":0.7218423003803937,"impliedVol":0.4897,"impliedVolPercentile":0.0317},"requestUrl":"/m/hq/s/MDGL","defaultTab":"news","newsList":[{"id":"2460417532","title":"Madrigal Pharmaceuticals, Inc.2024财年第二财季实现净利润-1.52亿美元，同比减少77.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460417532","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460417532?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824031,"startTime":"0","endTime":"0","summary":"8月17日，Madrigal Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-1.52亿美元，同比减少77.16%；其中营业收入为14.64百万美元，每股基本收益为-7.10美元。从资产负债表来看，Madrigal Pharmaceuticals, Inc.总负债2.43亿美元，其中短期债务557000.00美元，资产负债比为4.53，流动比率为8.74。机构评级：截至2024年8月17日，当前有15家机构对Madrigal Pharmaceuticals, Inc.目标价做出预测，其中目标均价为362.53美元，其中最低目标价为150.00美元，最高目标价为511.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005009f31b004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005009f31b004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL"],"gpt_icon":0},{"id":"1129569121","title":"异动解读 | Madrigal Pharmaceuticals股价大跌15%,新药患者人数低于预期引发投资者担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1129569121","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129569121?lang=zh_cn&edition=full","pubTime":"2024-08-08 03:14","pubTimestamp":1723058099,"startTime":"0","endTime":"0","summary":"Madrigal Pharmaceuticals, Inc.8月7日盘中股价大跌15.17%,引发市场广泛关注。根据相关报道,导致该公司股价大跌的主要原因是其最新获批的脂肪肝药物Rezdiffra的患者人数低于预期。据经纪公司杰富瑞透露,截至第二季度末,Rezdiffra的患者人数仅为2000名,远低于分析师预期的4000多名患者。一些投资者认为,接受该药物治疗的患者人数本应更多,公司对2025年Rezdiffra销售数据的表述也不太明确,这加剧了投资者对公司未来增长前景的担忧。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDGL"],"gpt_icon":0},{"id":"2457287687","title":"BUZZ-Madrigal因脂肪肝药物患者人数低于预期而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2457287687","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457287687?lang=zh_cn&edition=full","pubTime":"2024-08-08 03:11","pubTimestamp":1723057878,"startTime":"0","endTime":"0","summary":"    8月7日 - ** Madrigal Pharmaceuticals   股价下跌15.4%，跌至225.51美元的两个月低点。** 经纪公司杰富瑞称，截至第二季度末，MDGL最近获批的脂肪肝药物  Rezdiffra已有2000名患者，商业化率超过50%。** 一些投资者认为接受治疗的患者人数本应更多，而MDGL对2025年Rezdiffra数字的表述似乎不太明确--Jefferies。** 经纪公司 B.Riley 称，2000 名患者的数量大大低于 4000 多名患者的模型预测数量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","MDGL","BUZZ","BK4139"],"gpt_icon":0},{"id":"2457684924","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘快速下跌11.58%报235.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457684924","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457684924?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:33","pubTimestamp":1723037599,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时33分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价急速跳水11.58%。截至发稿，该股报235.70美元/股，成交量5.7572万股，换手率0.27%，振幅5.77%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大，Scorpius Holdings, Inc.、Aditxt, Inc.、Silo Pharma, Inc.较为活跃，换手率分别为266.13%、170.14%、42.50%，振幅较大的相关个股有Aditxt, Inc.、Neurosense Therapeutics Ltd.、天境生物，振幅分别为28.97%、14.49%、12.26%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072133199585f1da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072133199585f1da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","MDGL","BK4139","BK4588"],"gpt_icon":0},{"id":"2457072846","title":"Madrigal Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.08%报272.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457072846","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457072846?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:03","pubTimestamp":1722967417,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日02时03分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.08%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.88%。其相关个股中，Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1399.06%、1374.77%、499.42%，振幅较大的相关个股有Vbi Vaccines, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Alpha Tau Medical Ltd C/Wts ，振幅分别为168.52%、81.76%、78.49%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807020338968246a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807020338968246a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","MDGL","BK4585"],"gpt_icon":0},{"id":"2457470538","title":"Madrigal Pharmaceuticals Inc    预计每股亏损 7.53 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457470538","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457470538?lang=zh_cn&edition=full","pubTime":"2024-08-06 01:00","pubTimestamp":1722877219,"startTime":"0","endTime":"0","summary":"   * Madrigal Pharmaceuticals Inc    将于8月7日公布截至2024年6月30日的财报，预计季度收入将有所增长。* 根据LSEG的数据，13位分析师的平均预期显示，这家总部位于宾夕法尼亚州西康肖霍肯的公司预计将实现390.3万美元的营收。* LSEG 分析师对 Madrigal Pharmaceuticals Inc 的平均预期是每股亏损 7.53 美元。* 华尔街对 Madrigal Pharmaceuticals Inc 的 12 个月目标价中位数为 385.00 美元，高于其最新收盘价 275.36 美元。8月5日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Madrigal Pharmaceuticals Inc    预计每股亏损 7.53 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDGL"],"gpt_icon":0},{"id":"2457707720","title":"Madrigal Pharmaceuticals, Inc.盘中异动 股价大跌7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457707720","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457707720?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:30","pubTimestamp":1722864623,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时30分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅下挫7.61%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.55%。其相关个股中，Okyo Pharma Ltd Com Npv 、Briacell Therapeutics Corp C/Wts 24/02/2025、Alterity Therapeutics Limited涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为968.07%、30.43%、13.47%，振幅较大的相关个股有Cel-Sci Corporation、Onconetix, Inc.、Stoke Therapeutics, Inc.，振幅分别为8.70%、5.23%、5.08%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213023aefd4b81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213023aefd4b81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","MDGL","BK4585"],"gpt_icon":0},{"id":"2453036840","title":"坎托菲茨杰拉德公司：重申Madrigal Pharmaceuticals(MDGL.US)中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2453036840","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453036840?lang=zh_cn&edition=full","pubTime":"2024-07-23 20:09","pubTimestamp":1721736551,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","MDGL","BK4139","BK4588"],"gpt_icon":0},{"id":"2452089304","title":"Madrigal Pharmaceuticals, Inc.盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452089304","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452089304?lang=zh_cn&edition=full","pubTime":"2024-07-19 23:14","pubTimestamp":1721402089,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日23时14分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.27%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至23时14分，《JMP Securities维持Madrigal Pharmaceuticals买入评级，上调目标价至385美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192314509681e928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192314509681e928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","MDGL","BK4588"],"gpt_icon":0},{"id":"2452748444","title":"Madrigal Pharmaceuticals, Inc.盘中异动 股价大涨5.06%报283.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452748444","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452748444?lang=zh_cn&edition=full","pubTime":"2024-07-18 21:46","pubTimestamp":1721310389,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日21时46分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.06%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至21时46分，《JMP Securities维持Madrigal Pharmaceuticals买入评级，上调目标价至385美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718214629af92fd73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718214629af92fd73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2449046357","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449046357","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449046357?lang=zh_cn&edition=full","pubTime":"2024-07-08 23:07","pubTimestamp":1720451229,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日23时07分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.07%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。其相关个股中，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Morphic Holding, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为3356.14%、177.16%、143.17%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为121.11%、50.07%、40.77%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708230709aef87c03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708230709aef87c03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","MDGL"],"gpt_icon":0},{"id":"2446506554","title":"Madrigal Pharmaceuticals(MDGL.US)获坎托菲茨杰拉德公司首次覆盖，给予中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446506554","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446506554?lang=zh_cn&edition=full","pubTime":"2024-06-28 19:46","pubTimestamp":1719575195,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4139","MDGL","BK4585"],"gpt_icon":0},{"id":"2444217352","title":"Madrigal Pharmaceuticals, Inc.盘中异动 股价大跌5.14%报261.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444217352","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444217352?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:41","pubTimestamp":1718890893,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时41分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.14%。截至发稿，该股报261.84美元/股，成交量2.1786万股，换手率0.10%，振幅2.85%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214133968157ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214133968157ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2442634820","title":"Madrigal Pharmaceuticals(MDGL.US)获Wolfe Research首次覆盖，给予优于大市评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2442634820","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442634820?lang=zh_cn&edition=full","pubTime":"2024-06-12 02:37","pubTimestamp":1718131076,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDGL","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2441069164","title":"Madrigal Pharmaceuticals, Inc.盘中异动 急速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441069164","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441069164?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:41","pubTimestamp":1717767716,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日21时41分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.08%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至21时41分，《JMP Securities维持Madrigal Pharmaceuticals买入评级，维持目标价381美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607214157af8ca97e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607214157af8ca97e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","MDGL","BK4585","BK4139"],"gpt_icon":0},{"id":"2441171067","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441171067","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441171067?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:37","pubTimestamp":1717681063,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时37分，Madrigal Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.02%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至21时37分，《JMP Securities维持Madrigal Pharmaceuticals买入评级，维持目标价381美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213744af8c6a72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213744af8c6a72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4588","BK4585","BK4139"],"gpt_icon":0},{"id":"2441482270","title":"BUZZ-在礼来公司的肥胖症药物显示出对肝脏疤痕的益处后，NASH 药物开发商倒下了","url":"https://stock-news.laohu8.com/highlight/detail?id=2441482270","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441482270?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:09","pubTimestamp":1717600192,"startTime":"0","endTime":"0","summary":"    6月5日 - ** NASH药物开发商Madrigal Pharmaceuticals   股价下跌约10%，报220.76美元；Akero Therapeutics   下跌3.3%，报18.58美元；89Bio   下跌约2%，报8.19美元。** 礼来  报告了其肥胖症药物的中期研究数据，该药物正在一种以前被称为NASH、现在被称为代谢功能障碍相关性脂肪性肝炎的严重脂肪肝患者中进行测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491049909.HKD","GB00BDT5M118.USD","LU1551013342.USD","LU2468319806.SGD","LU0097036916.USD","BK4533","LLY","IE0009355771.USD","LU2237443549.SGD","BK4007","IE00B1BXHZ80.USD","LU0058720904.USD","LU1551013425.SGD","MDGL","LU0061475181.USD","LU0114720955.EUR","LU1623119135.USD","AKRO","LU1804176565.USD","LU2237443978.SGD","LU2237443382.USD","LU0708995401.HKD","LU1280957306.USD","LU0122379950.USD","LU0256863811.USD","LU1988902786.USD","LU0882574139.USD","LU1057294990.SGD","BUZZ","LU2264538146.SGD","IE00BJT1NW94.SGD","LU1814569148.SGD","BK4534","LU2237443622.USD","ETNB","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU1712237335.SGD","LU0820561909.HKD","LU2265009873.SGD","LU0943347566.SGD","LU2491050071.SGD","LU2491050154.USD","LU0689472784.USD","LU1023059063.AUD","IE0002141913.USD","LU0882574055.USD","LU0109391861.USD","IE0004445239.USD","LU0079474960.USD"],"gpt_icon":0},{"id":"2441625279","title":"Madrigal Pharmaceuticals, Inc.股价重挫13.98% 市值跌6.26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441625279","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441625279?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:31","pubTimestamp":1717594317,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日21时31分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价快速下挫13.98%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。消息层面，截至21时31分，《JMP Securities维持Madrigal Pharmaceuticals买入评级，维持目标价381美元》资讯为影响Madrigal Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060521315795914e24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060521315795914e24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","MDGL","BK4588"],"gpt_icon":0},{"id":"2435437971","title":"Madrigal Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435437971","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435437971?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:39","pubTimestamp":1715611154,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时39分，Madrigal Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.15%。Madrigal Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。Madrigal Pharmaceuticals, Inc.公司简介：Madrigal Pharmaceuticals Inc是一家临床阶段生物制药公司。该信息摘要如下：B. Riley Securities：维持Madrigal Pharmaceuticals评级，由中性调整至中性评级, 目标价由270.00美元调整至200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513223915861ecd86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513223915861ecd86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2435356716","title":"Madrigal Pharmaceuticals, Inc.2024财年第一财季实现净利润-1.48亿美元，同比减少92.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435356716","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435356716?lang=zh_cn&edition=full","pubTime":"2024-05-13 00:12","pubTimestamp":1715530361,"startTime":"0","endTime":"0","summary":"3月31日，Madrigal Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为-1.48亿美元，同比减少92.46%；其中营业收入为0.00美元，每股基本收益为-7.38美元。从资产负债表来看，Madrigal Pharmaceuticals, Inc.总负债2.32亿美元，其中短期债务542000.00美元，资产负债比为4.67，流动比率为9.43。机构评级：截至2024年3月31日，当前有14家机构对Madrigal Pharmaceuticals, Inc.目标价做出预测，其中目标均价为363.86美元，其中最低目标价为150.00美元，最高目标价为507.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513001251875f0129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513001251875f0129&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.madrigalpharma.com","stockEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":-0.1039},{"period":"3month","weight":0.1009},{"period":"6month","weight":0.0685},{"period":"1year","weight":0.4257},{"period":"ytd","weight":0.0923}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Madrigal Pharmaceuticals, Inc.于2000年3月成立并在2001年7月开始运营。 Synta制药公司是一家生物制药公司，致力于发现、开发和商业化小分子药物以扩大和加强带有严重疾病的患者的生命，包括癌症和慢性症性疾病。该公司有两种候选药物在临床实验中用于治疗多种类型的癌症和几个用于临床前研究阶段的候选药物。所有公司的候选药物利用公司的专利、独特的化合物和集成的发现引擎发现。这家公司保留了其候选药物的全部选择权。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.032263},{"month":2,"riseRate":0.75,"avgChangeRate":0.088162},{"month":3,"riseRate":0.25,"avgChangeRate":-0.038862},{"month":4,"riseRate":0.5,"avgChangeRate":0.008688},{"month":5,"riseRate":0.375,"avgChangeRate":0.168822},{"month":6,"riseRate":0.625,"avgChangeRate":0.024173},{"month":7,"riseRate":0.125,"avgChangeRate":-0.088753},{"month":8,"riseRate":0.555556,"avgChangeRate":0.060355},{"month":9,"riseRate":0.375,"avgChangeRate":0.16708},{"month":10,"riseRate":0.625,"avgChangeRate":0.051439},{"month":11,"riseRate":0.5,"avgChangeRate":0.037474},{"month":12,"riseRate":0.5,"avgChangeRate":0.475789}],"exchange":"NASDAQ","name":"Madrigal Pharmaceuticals, Inc.","nameEN":"Madrigal Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Madrigal Pharmaceuticals, Inc.,MDGL,Madrigal Pharmaceuticals, Inc.股票,Madrigal Pharmaceuticals, Inc.股票老虎,Madrigal Pharmaceuticals, Inc.股票老虎国际,Madrigal Pharmaceuticals, Inc.行情,Madrigal Pharmaceuticals, Inc.股票行情,Madrigal Pharmaceuticals, Inc.股价,Madrigal Pharmaceuticals, Inc.股市,Madrigal Pharmaceuticals, Inc.股票价格,Madrigal Pharmaceuticals, Inc.股票交易,Madrigal Pharmaceuticals, Inc.股票购买,Madrigal Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}